z-logo
open-access-imgOpen Access
Periplasmic domain of the sensor-kinase BvgS reveals a new paradigm for the Venus flytrap mechanism
Author(s) -
Julien Herrou,
Coralie Bompard,
René Wintjens,
Elian Dupré,
Eve Willery,
Vincent Villeret,
Camille Locht,
Rudy Antoine,
Françoise JacobDubuisson
Publication year - 2010
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1006267107
Subject(s) - periplasmic space , regulon , microbiology and biotechnology , biology , signal transduction , bordetella pertussis , transcription factor , biochemistry , genetics , gene , escherichia coli , bacteria
Two-component sensory transduction systems control important bacterial programs. In Bordetella pertussis, expression of the virulence regulon is controlled by the unorthodox BvgAS two-component system. BvgS is the prototype of a family of sensor-kinases that harbor periplasmic domains homologous to bacterial solute-binding proteins. Although BvgAS is active under laboratory conditions, no activating signal has been identified, only negative modulators. Here we show that the second periplasmic domain of BvgS interacts with modulators and adopts a Venus flytrap (VFT) fold. X-ray crystallography reveals that the two lobes of VFT2 delimitate a ligand-binding cavity enclosing fortuitous ligands. Most substitutions of putative ligand-binding residues in the VFT2 cavity keep BvgS active, and alteration of the cavity's electrostatic potential affects responsiveness to modulation. The crystal structure of this VFT2 variant conferring constitutive kinase activity to BvgS shows a closed cavity with another nonspecific ligand. Thus, VFT2 is closed and active without a specific agonist ligand, in contrast to typical VFTs. Modulators are antagonists of VFT2 that interrupt signaling. BvgAS is active for most of the B. pertussis infectious cycle, consistent with the proposed mechanism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here